Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President & CEO, Director
-
Stock Symbol
-
CCCC on Nasdaq
There are no Buy or Sell transactions made by Andrew Hirsch since 11/5/2023
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
215K |
$1.37M |
$6.36 |
Sep 16, 2024 |
Direct |
|
|
| Performance Restricted Stock Units |
47.5K |
$302K |
$6.36 |
Sep 16, 2024 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
466K |
|
|
Feb 14, 2024 |
Direct |
Common Stock |
|
Transactions reported by Andrew Hirsch for C4 Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.